Trials / Completed
CompletedNCT01703741
A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel
A Multicenter Extension Trial to Evaluate the Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 145 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Male
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter extension trial in adult hypogonadal males. The purpose of this study is to evaluate the safety of testosterone gel delivered using an applicator over an extended period of time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Testosterone Gel (FE 999093) |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2012-10-10
- Last updated
- 2017-10-06
- Results posted
- 2017-10-06
Locations
18 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT01703741. Inclusion in this directory is not an endorsement.